Polarized Airway Epithelial Models for Immunological Co-Culture Studies

International Archives of Allergy and Immunology

Volumn 170, Issue 1, 2016, Pages 1-21

  Papazian, Dick ^a,b   Würtzen, Peter A ^b   Hansen, Soren W K ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ALK ABELLÓ   (Denmark)

Author keywords

Airway epithelium; Co culture models; Dendritic cells; Immune homeostasis; T cells; Tolerance

Indexed keywords

ALLERGEN; ANTIGEN; MATRIX PROTEIN; MEMBRANE PROTEIN; TIGHT JUNCTION PROTEIN; UVOMORULIN;

A549 CELL LINE; ACUTE LUNG INJURY; AIRWAY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ASTHMA; BRONCHUS; CELL CONTACT; CELL CULTURE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL POLARITY; CELL STRUCTURE; CELLS BY BODY ANATOMY; COCULTURE; CONFOCAL MICROSCOPY; CULTURE MEDIUM; DENDRITIC CELL; EPITHELIUM CELL; EX VIVO STUDY; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM CELL; NONHUMAN; NOSE; PRIMARY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT MUCOSA; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TRANSEPITHELIAL RESISTANCE; ANIMAL; CELL COMMUNICATION; CELL LINE; CYTOLOGY; DIFFUSION; IMMUNOLOGY; IMPEDANCE; METABOLISM; PHYSIOLOGY; RESPIRATORY MUCOSA;

ALLERGENS; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CELL COMMUNICATION; CELL LINE; COCULTURE TECHNIQUES; DIFFUSION; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; HUMANS; IN VITRO TECHNIQUES; MICROSCOPY, CONFOCAL; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

EID: 84980439084     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000445833     Document Type: Review

References (204)

1. Beasley R, Crane J, Lai CK, Pearce N: Prevalence and etiology of asthma. J Allergy Clin Immunol 2000; 105:S466-S472.
2. Iwasaki A: Mucosal dendritic cells. Annu Rev Immunol 2007; 25: 381-418.
3. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM: Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 2010; 107: 11489-11494.
4. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, McKenzie AN: Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464: 1367-1370.
5. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S: Innate production of T H 2 cytokines by adipose tissue-associated c-Kit + Sca-1 + lymphoid cells. Nature 2010; 463: 540-544.
6. Klein Wolterink RG, Kleinjan A, van Nimwegen M, Bergen I, de Bruijn M, Levani Y, Hendriks RW: Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 2012; 42: 1106-1116.
7. Toppila-Salmi S, Renkonen J, Joenvaara S, Mattila P, Renkonen R: Allergen interactions with epithelium. Curr Opin Allergy Clin Immunol 2011; 11: 29-32.
8. Jacquet A: The role of the house dust miteinduced innate immunity in development of allergic response. Int Arch Allergy Immunol 2011; 155: 95-105.
9. Holgate ST: Has the time come to rethink the pathogenesis of asthma? Curr Opin Allergy Clin Immunol 2010; 10: 48-53.
10. Lambrecht BN, Hammad H: Biology of lung dendritic cells at the origin of asthma. Immunity 2009; 31: 412-424.
11. Lambrecht BN, Hammad H: The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 2010; 376: 835-843.
12. Poynter ME: Airway epithelial regulation of allergic sensitization in asthma. Pulm Pharmacol Ther 2012; 25: 438-446.
13. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN: House dust mite allergen induces asthma via Tolllike receptor 4 triggering of airway structural cells. Nat Med 2009; 15: 410-416.
14. Boulenc X, Marti E, Joyeux H, Roques C, Berger Y, Fabre G: Importance of the paracellular pathway for the transport of a new bisphosphonate using the human CACO-2 monolayers model. Biochem Pharmacol 1993; 46: 1591-1600.
15. Bur M, Huwer H, Muys L, Lehr CM: Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique. J Aerosol Med Pulm Drug Deliv 2010; 23: 119-127.
16. Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S, Peri F, Wilson SW, Ruhrberg C: Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010; 116: 829-840.
17. Inui K, Yamamoto M, Saito H: Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes. J Pharmacol Exp Ther 1992; 261: 195-201.
18. Pflicke H, Sixt M: Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J Exp Med 2009; 206: 2925-2935.
19. Steimer A, Haltner E, Lehr CM: Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J Aerosol Med 2005; 18: 137-182.
20. Itoh H, Nishino M, Hatabu H: Architecture of the lung: morphology and function. J Thorac Imaging 2004; 19: 221-227.
21. Gil J, Weibel ER: Extracellular lining of bronchioles after perfusion-fixation of rat lungs for electron microscopy. Anat Rec 1971; 169: 185-199.
22. Schurch S, Gehr P, Im Hof V, Geiser M, Green F: Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol 1990; 80: 17-32.
23. Kilburn KH: A hypothesis for pulmonary clearance and its implications. Am Rev Respir Dis 1968; 98: 449-463.
24. Holt PG, Schon-Hegrad MA, McMenamin PG: Dendritic cells in the respiratory tract. Int Rev Immunol 1990; 6: 139-149.
25. Lehnert BE: Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung. Environ Health Perspect 1992; 97: 17-46.
26. Godfrey RW: Human airway epithelial tight junctions. Microsc Res Tech 1997; 38: 488-499.
27. Schneeberger EE, Lynch RD: Tight junctions: their structure, composition, and function. Circ Res 1984; 55: 723-733.
28. McDowell EM, Barrett LA, Glavin F, Harris CC, Trump BF: The respiratory epithelium. I. Human bronchus. J Natl Cancer Inst 1978; 61: 539-549.
29. Jeffery PK, Reid L: New observations of rat airway epithelium: a quantitative and electron microscopic study. J Anat 1975; 120: 295-320.
30. Stone KC, Mercer RR, Gehr P, Stockstill B, Crapo JD: Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol 1992; 6: 235-243.
31. Mason RJ, Crystal RG: Pulmonary cell biology. Am J Respir Crit Care Med 1998; 157:S72-S81.
32. Willart MA, Lambrecht BN: The danger within: endogenous danger signals, atopy and asthma. Clin Exp Allergy 2009; 39: 12-19.
33. Raz E: Organ-specific regulation of innate immunity. Nat Immunol 2007; 8: 3-4.
34. Mayer AK, Dalpke AH: Regulation of local immunity by airway epithelial cells. Arch Immunol Ther Exp (Warsz) 2007; 55: 353-362.
35. Mayer AK, Muehmer M, Mages J, Gueinzius K, Hess C, Heeg K, Bals R, Lang R, Dalpke AH: Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J Immunol 2007; 178: 3134-3142.
36. Stuart LM, Deng J, Silver JM, Takahashi K, Tseng AA, Hennessy EJ, Ezekowitz RA, Moore KJ: Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol 2005; 170: 477-485.
37. Matsuwaki Y, Wada K, White T, Moriyama H, Kita H: Alternaria fungus induces the production of GM-CSF, interleukin-6 and interleukin-8 and calcium signaling in human airway epithelium through protease-activated receptor 2. Int Arch Allergy Immunol 2012; 158(suppl 1):19-29.
38. Osterlund C, Gronlund H, Gafvelin G, Bucht A: Non-proteolytic aeroallergens from mites, cat and dog exert adjuvant-like activation of bronchial epithelial cells. Int Arch Allergy Immunol 2011; 155: 111-118.
39. Hayashi T, Beck L, Rossetto C, Gong X, Takikawa O, Takabayashi K, Broide DH, Carson DA, Raz E: Inhibition of experimental asthma by indoleamine 2, 3-dioxygenase. J Clin Invest 2004; 114: 270-279.
40. Monick MM, Yarovinsky TO, Powers LS, Butler NS, Carter AB, Gudmundsson G, Hunninghake GW: Respiratory syncytial virus upregulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem 2003; 278: 53035-53044.
41. Pace E, Ferraro M, Siena L, Melis M, Montalbano AM, Johnson M, Bonsignore MR, Bonsignore G, Gjomarkaj M: Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells. Immunology 2008; 124: 401-411.
42. Poynter ME, Irvin CG, Janssen-Heininger YM: Rapid activation of nuclear factor-B in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol 2002; 160: 1325-1334.
43. Ather JL, Hodgkins SR, Janssen-Heininger YM, Poynter ME: Airway epithelial NF-B activation promotes allergic sensitization to an innocuous inhaled antigen. Am J Respir Cell Mol Biol 2011; 44: 631-638.
44. Broide DH, Lawrence T, Doherty T, Cho JY, Miller M, McElwain K, McElwain S, Karin M: Allergen-induced peribronchial fibrosis and mucus production mediated by I?B kinase dependent genes in airway epithelium. Proc Natl Acad Sci USA 2005; 102: 17723-17728.
45. Schneeberger EE: Heterogeneity of tight junction morphology in extrapulmonary and intrapulmonary airways of the rat. Anat Rec 1980; 198: 193-208.
46. Hartsock A, Nelson WJ: Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 2008; 1778: 660-669.
47. Mullin JM, Agostino N, Rendon-Huerta E, Thornton JJ: Keynote review: epithelial and endothelial barriers in human disease. Drug Discov Today 2005; 10: 395-408.
48. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S: Claudin-1 and-2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 141: 1539-1550.
49. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S: Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123: 1777-1788.
50. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, Simmons D, Dejana E: Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998; 142: 117-127.
51. Holgate ST: Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007; 120: 1233-1244; quiz 1245-1236.
52. Roche WR, Montefort S, Baker J, Holgate ST: Cell adhesion molecules and the bronchial epithelium. Am Rev Respir Dis 1993; 148:S79-S82.
53. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, Pochet M, Parkos CA: Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 2000; 113(pt 13): 2363-2374.
54. Mitic LL, van Itallie CM, Anderson JM: Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 2000; 279:G250-G254.
55. Tsukita S, Furuse M: Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000; 149: 13-16.
56. Apodaca G, Gallo LI, Bryant DM: Role of membrane traffic in the generation of epithelial cell asymmetry. Nat Cell Biol 2012; 14: 1235-1243.
57. Willenborg C, Prekeris R: Apical protein transport and lumen morphogenesis in polarized epithelial cells. Biosci Rep 2011; 31: 245-256.
58. de Boer WI, Sharma HS, Baelemans SM, Hoogsteden HC, Lambrecht BN, Braunstahl GJ: Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. Can J Physiol Pharmacol 2008; 86: 105-112.
59. Jiang A, Bloom O, Ono S, Cui W, Unternaehrer J, Jiang S, Whitney JA, Connolly J, Banchereau J, Mellman I: Disruption of Ecadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007; 27: 610-624.
60. Nawijn MC, Hackett TL, Postma DS, van Oosterhout AJ, Heijink IH: E-cadherin: gatekeeper of airway mucosa and allergic sensitization. Trends Immunol 2011; 32: 248-255.
61. Heijink IH, Kies PM, Kauffman HF, Postma DS, van Oosterhout AJ, Vellenga E: Downregulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptor-dependent Th2 cell-promoting activity. J Immunol 2007; 178: 7678-7685.
62. Pichavant M, Charbonnier AS, Taront S, Brichet A, Wallaert B, Pestel J, Tonnel AB, Gosset P: Asthmatic bronchial epithelium activated by the proteolytic allergen Der p 1 increases selective dendritic cell recruitment. J Allergy Clin Immunol 2005; 115: 771-778.
63. Angkasekwinai P, Park H, Wang YH, Wang YH, Chang SH, Corry DB, Liu YJ, Zhu Z, Dong C: Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204: 1509-1517.
64. Saenz SA, Taylor BC, Artis D: Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 2008; 226: 172-190.
65. Takizawa H, Ohtoshi T, Ohta K, Hirohata S, Yamaguchi M, Suzuki N, Ueda T, Ishii A, Shindoh G, Oka T, et al: Interleukin 6/b cell stimulatory factor-II is expressed and released by normal and transformed human bronchial epithelial cells. Biochem Biophys Res Commun 1992; 187: 596-602.
66. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA: Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 1997; 185: 461-469.
67. Papazian D, Hansen S, Wurtzen PA: Airway responses towards allergens-from the airway epithelium to T cells. Clin Exp Allergy 2015; 45: 1268-1287.
68. Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M: Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009; 2: 340-350.
69. Iliev ID, Spadoni I, Mileti E, Matteoli G, Sonzogni A, Sampietro GM, Foschi D, Caprioli F, Viale G, Rescigno M: Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009; 58: 1481-1489.
70. Rimoldi M, Chieppa M, Larghi P, Vulcano M, Allavena P, Rescigno M: Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 2005; 106: 2818-2826.
71. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM, Nespoli A, Viale G, Allavena P, Rescigno M: Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005; 6: 507-514.
72. Papazian D, Chhoden T, Arge M, Vorup-Jensen T, Nielsen CH, Lund K, Wurtzen PA, Hansen S: Polarization affects airway epithelial conditioning of monocyte-derived dendritic cells. Am J Respir Cell Mol Biol 2015; 53: 368-377.
73. Gehr P, Bachofen M, Weibel ER: The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol 1978; 32: 121-140.
74. Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J: Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med 1997; 155: 1376-1383.
75. Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA: Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med 2001; 193: 51-60.
76. Holt PG: Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract. Proc Am Thorac Soc 2005; 2: 116-120.
77. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P: Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2: 361-367.
78. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, Littman DR, Reinecker HC: Cx3cr1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005; 307: 254-258.
79. Takano K, Kojima T, Go M, Murata M, Ichimiya S, Himi T, Sawada N: HLA-DR-and CD11c-positive dendritic cells penetrate beyond well-developed epithelial tight junctions in human nasal mucosa of allergic rhinitis. J Histochem Cytochem 2005; 53: 611-619.
80. Blume C, Foerster S, Gilles S, Becker WM, Ring J, Behrendt H, Petersen A, Traidl-Hoffmann C: Human epithelial cells of the respiratory tract and the skin differentially internalize grass pollen allergens. J Invest Dermatol 2009; 129: 1935-1944.
81. Renkonen J, Mattila P, Lehti S, Makinen J, Sormunen R, Tervo T, Paavonen T, Renkonen R: Birch pollen allergen Bet v 1 binds to and is transported through conjunctival epithelium in allergic patients. Allergy 2009; 64: 868-875.
82. Joenvaara S, Mattila P, Renkonen J, Makitie A, Toppila-Salmi S, Lehtonen M, Salmi P, Lehti S, Makinen J, Sormunen R, Paavonen T, Renkonen R: Caveolar transport through nasal epithelium of birch pollen allergen Bet v 1 in allergic patients. J Allergy Clin Immunol 2009; 124: 135-142. e21.
83. Debbabi H, Ghosh S, Kamath AB, Alt J, Demello DE, Dunsmore S, Behar SM: Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells. Am J Physiol Lung Cell Mol Physiol 2005; 289:L274-L279.
84. Gereke M, Jung S, Buer J, Bruder D: Alveolar type II epithelial cells present antigen to CD4 + T cells and induce foxp3 + regulatory T cells. Am J Respir Crit Care Med 2009; 179: 344-355.
85. Cunningham AC, Zhang JG, Moy JV, Ali S, Kirby JA: A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells. Immunology 1997; 91: 458-463.
86. Lo B, Hansen S, Evans K, Heath JK, Wright JR: Alveolar epithelial type II cells induce T cell tolerance to specific antigen. J Immunol 2008; 180: 881-888.
87. Blank F, Rothen-Rutishauser B, Gehr P: Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol 2007; 36: 669-677.
88. Ehrhardt C, Kneuer C, Fiegel J, Hanes J, Schaefer UF, Kim KJ, Lehr CM: Influence of apical fluid volume on the development of functional intercellular junctions in the human epithelial cell line 16HBE14o-: implications for the use of this cell line as an in vitro model for bronchial drug absorption studies. Cell Tissue Res 2002; 308: 391-400.
89. Grainger CI, Greenwell LL, Lockley DJ, Martin GP, Forbes B: Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm Res 2006; 23: 1482-1490.
90. Lehmann AD, Daum N, Bur M, Lehr CM, Gehr P, Rothen-Rutishauser BM: An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. Eur J Pharm Biopharm 2011; 77: 398-406.
91. Man Y, Hart VJ, Ring CJ, Sanjar S, West MR: Loss of epithelial integrity resulting from Ecadherin dysfunction predisposes airway epithelial cells to adenoviral infection. Am J Respir Cell Mol Biol 2000; 23: 610-617.
92. Mathia NR, Timoszyk J, Stetsko PI, Megill JR, Smith RL, Wall DA: Permeability characteristics of Calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats. J Drug Target 2002; 10: 31-40.
93. Wan H, Winton HL, Soeller C, Stewart GA, Thompson PJ, Gruenert DC, Cannell MB, Garrod DR, Robinson C: Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o-. Eur Respir J 2000; 15: 1058-1068.
94. Yamaya M, Finkbeiner WE, Chun SY, Widdicombe JH: Differentiated structure and function of cultures from human tracheal epithelium. Am J Physiol 1992; 262:L713-L724.
95. Hidalgo IJ, Raub TJ, Borchardt RT: Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 96: 736-749.
96. Bur M, Huwer H, Lehr CM, Hagen N, Guldbrandt M, Kim KJ, Ehrhardt C: Assessment of transport rates of proteins and peptides across primary human alveolar epithelial cell monolayers. Eur J Pharm Sci 2006; 28: 196-203.
97. Widdicombe J: Airway and alveolar permeability and surface liquid thickness: theory. J Appl Physiol (1985) 1997; 82: 3-12.
98. Bai S, Yang T, Abbruscato TJ, Ahsan F: Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies. J Pharm Sci 2008; 97: 1165-1178.
99. Forbes B, Shah A, Martin GP, Lansley AB: The human bronchial epithelial cell line 16HBE14o-as a model system of the airways for studying drug transport. Int J Pharm 2003; 257: 161-167.
100. Yang T, Hussain A, Paulson J, Abbruscato TJ, Ahsan F: Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies. Pharm Res 2004; 21: 1127-1136.
101. Yang T, Mustafa F, Bai S, Ahsan F: Pulmonary delivery of low molecular weight heparins. Pharm Res 2004; 21: 2009-2016.
102. Elbert KJ, Schafer UF, Schafers HJ, Kim KJ, Lee VH, Lehr CM: Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharm Res 1999; 16: 601-608.
103. Kobayashi S, Kondo S, Juni K: Permeability of peptides and proteins in human cultured alveolar A549 cell monolayer. Pharm Res 1995; 12: 1115-1119.
104. Leonard M, Creed E, Brayden D, Baird AW: Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport. Pharm Res 2000; 17: 1181-1188.
105. Sarl E: Protocol 'TEER (Trans Epithelial Electrical Resistance) measurement'. You-Tube, 2013.
106. Sporty JL, Horalkova L, Ehrhardt C: In vitro cell culture models for the assessment of pulmonary drug disposition. Expert Opin Drug Metab Toxicol 2008; 4: 333-345.
107. Stewart CE, Torr EE, Mohd Jamili NH, Bosquillon C, Sayers I: Evaluation of differentiated human bronchial epithelial cell culture systems for asthma research. J Allergy (Cairo) 2012; 2012: 943982.
108. Borchardt RT: Hidalgo, I. J., Raub, T. J., and Borchardt, R. T. : Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology, 96, 736-749, 1989-the backstory. AAPS J 2011; 13: 323-327.
109. Bleck B, Tse DB, Curotto de Lafaille MA, Zhang F, Reibman J: Diesel exhaust particleexposed human bronchial epithelial cells induce dendritic cell maturation and polarization via thymic stromal lymphopoietin. J Clin Immunol 2008; 28: 147-156.
110. Bleck B, Tse DB, Jaspers I, Curotto de Lafaille MA, Reibman J: Diesel exhaust particle-exposed human bronchial epithelial cells induce dendritic cell maturation. J Immunol 2006; 176: 7431-7437.
111. Blank F, Rothen-Rutishauser BM, Schurch S, Gehr P: An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med 2006; 19: 392-405.
112. Papazian D, Wagtmann VR, Hansen S, Wurtzen PA: Direct contact between dendritic cells and bronchial epithelial cells inhibits T cell recall responses towards mite and pollen allergen extracts in vitro. Clin Exp Immunol 2015; 181: 207-218.
113. Rate A, Upham JW, Bosco A, McKenna KL, Holt PG: Airway epithelial cells regulate the functional phenotype of locally differentiating dendritic cells: implications for the pathogenesis of infectious and allergic airway disease. J Immunol 2009; 182: 72-83.
114. Gruber FP, Hartung T: Alternatives to animal experimentation in basic research. ALTEX 2004; 21(suppl 1):3-31.
115. Rothen-Rutishauser B, Blank F, Muhlfeld C, Gehr P: In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin Drug Metab Toxicol 2008; 4: 1075-1089.
116. Lin H, Li H, Cho HJ, Bian S, Roh HJ, Lee MK, Kim JS, Chung SJ, Shim CK, Kim DD: Airliquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies. J Pharm Sci 2007; 96: 341-350.
117. Black PN, Ghatei MA, Takahashi K, Bretherton-Watt D, Krausz T, Dollery CT, Bloom SR: Formation of endothelin by cultured airway epithelial cells. FEBS Lett 1989; 255: 129-132.
118. Kaufman DG: Biochemical studies of isolated hamster tracheal epithelium. Environ Health Perspect 1976; 16: 99-110.
119. Mathias NR, Kim KJ, Robison TW, Lee VH: Development and characterization of rabbit tracheal epithelial cell monolayer models for drug transport studies. Pharm Res 1995; 12: 1499-1505.
120. Oreffo VI, Morgan A, Richards RJ: Isolation of Clara cells from the mouse lung. Environ Health Perspect 1990; 85: 51-64.
121. Merkle HP, Ditzinger G, Lang SR, Peter H, Schmidt MC: In vitro cell models to study nasal mucosal permeability and metabolism. Adv Drug Deliv Rev 1998; 29: 51-79.
122. Chevillard M, Hinnrasky J, Pierrot D, Zahm JM, Klossek JM, Puchelle E: Differentiation of human surface upper airway epithelial cells in primary culture on a floating collagen gel. Epithelial Cell Biol 1993; 2: 17-25.
123. Ohnishi M, Ruhno J, Bienenstock J, Dolovich J, Denburg JA: Hematopoietic growth factor production by cultured cells of human nasal polyp epithelial scrapings: kinetics, cell source, and relationship to clinical status. J Allergy Clin Immunol 1989; 83: 1091-1100.
124. Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H: Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12: 1055-1062.
125. Bernstein JM, Yankaskas JR: Increased ion transport in cultured nasal polyp epithelial cells. Arch Otolaryngol Head Neck Surg 1994; 120: 993-996.
126. Gruenert DC, Finkbeiner WE, Widdicombe JH: Culture and transformation of human airway epithelial cells. Am J Physiol 1995; 268:L347-L360.
127. Galietta LJ, Lantero S, Gazzolo A, Sacco O, Romano L, Rossi GA, Zegarra-Moran O: An improved method to obtain highly differentiated monolayers of human bronchial epithelial cells. In Vitro Cell Dev Biol Anim 1998; 34: 478-481.
128. Gray TE, Guzman K, Davis CW, Abdullah LH, Nettesheim P: Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol 1996; 14: 104-112.
129. Yoon JH, Moon HJ, Seong JK, Kim CH, Lee JJ, Choi JY, Song MS, Kim SH: Mucociliary differentiation according to time in human nasal epithelial cell culture. Differentiation 2002; 70: 77-83.
130. Hermanns MI, Fuchs S, Bock M, Wenzel K, Mayer E, Kehe K, Bittinger F, Kirkpatrick CJ: Primary human coculture model of alveolo-capillary unit to study mechanisms of injury to peripheral lung. Cell Tissue Res 2009; 336: 91-105.
131. Forbes B, Ehrhardt C: Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 2005; 60: 193-205.
132. Chemuturi NV, Hayden P, Klausner M, Donovan MD: Comparison of human tracheal/ bronchial epithelial cell culture and bovine nasal respiratory explants for nasal drug transport studies. J Pharm Sci 2005; 94: 1976-1985.
133. GeurtsvanKessel CH, Lambrecht BN: Division of labor between dendritic cell subsets of the lung. Mucosal Immunol 2008; 1: 442-450.
134. Allam JP, Wurtzen PA, Reinartz M, Winter J, Vrtala S, Chen KW, Valenta R, Wenghoefer M, Appel T, Gros E, Niederhagen B, Bieber T, Lund K, Novak N: Phl p 5 resorption in human oral mucosa leads to dosedependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-1 and IL-10-producing properties. J Allergy Clin Immunol 2010; 126: 638-645. e1.
135. Kicic A, Sutanto EN, Stevens PT, Knight DA, Stick SM: Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. Am J Respir Crit Care Med 2006; 174: 1110-1118.
136. Kicic A, Hallstrand TS, Sutanto EN, Stevens PT, Kobor MS, Taplin C, Pare PD, Beyer RP, Stick SM, Knight DA: Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. Am J Respir Crit Care Med 2010; 181: 889-898.
137. Stevens PT, Kicic A, Sutanto EN, Knight DA, Stick SM: Dysregulated repair in asthmatic paediatric airway epithelial cells: the role of plasminogen activator inhibitor-1. Clin Exp Allergy 2008; 38: 1901-1910.
138. Hackett TL, Singhera GK, Shaheen F, Hayden P, Jackson GR, Hegele RG, van Eeden S, Bai TR, Dorscheid DR, Knight DA: Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to respiratory syncytial virus and air pollution. Am J Respir Cell Mol Biol 2011; 45: 1090-1100.
139. Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I, Haitchi HM, Vernon-Wilson E, Sammut D, Bedke N, Cremin C, Sones J, Djukanovic R, Howarth PH, Collins JE, Holgate ST, Monk P, Davies DE: Defective epithelial barrier function in asthma. J Allergy Clin Immunol 2011; 128: 549-556. e12.
140. Sakagami M: In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 2006; 58: 1030-1060.
141. Moore GE, Sandberg AA: Studies of a human tumor cell line with a diploid karyotype. Cancer 1964; 17: 170-175.
142. Moll R, Krepler R, Franke WW: Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 1983; 23: 256-269.
143. Moorhead PS: Human tumor cell line with a quasi-diploid karyotype (RPMI 2650). Exp Cell Res 1965; 39: 190-196.
144. Boucher RC, Yankaskas JR, Cotton CU, Knowles MR, Stutts MJ: Cell culture approaches to the investigation of human airway ion transport. Eur J Respir Dis Suppl 1987; 153: 59-67.
145. Werner U, Kissel T: In-vitro cell culture models of the nasal epithelium: a comparative histochemical investigation of their suitability for drug transport studies. Pharm Res 1996; 13: 978-988.
146. De Fraissinette A, Brun R, Felix H, Vonderscher J, Rummelt A: Evaluation of the human cell line RPMI 2650 as an in vitro nasal model. Rhinology 1995; 33: 194-198.
147. Fogh J, Trempe G: New human tumor cell lines; in Fogh J (ed): Human Tumor Cells in vitro. New York, Springer, 1975.
148. Patel J, Pal D, Vangal V, Gandhi M, Mitra AL: Transport of HIV-protease inhibitors across 1 alpha, 25di-hydroxy Vitamin D3-treated Calu-3 cell monolayers: modulation of P-glycoprotein activity. Pharm Res 2002; 19: 1696-1703.
149. Pezron I, Mitra R, Pal D, Mitra AK: Insulin aggregation and asymmetric transport across human bronchial epithelial cell monolayers (Calu-3). J Pharm Sci 2002; 91: 1135-1146.
150. Fiegel J, Ehrhardt C, Schaefer UF, Lehr CM, Hanes J: Large porous particle impingement on lung epithelial cell monolayers-toward improved particle characterization in the lung. Pharm Res 2003; 20: 788-796.
151. Foster KA, Avery ML, Yazdanian M, Audus KL: Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery. Int J Pharm 2000; 208: 1-11.
152. Shen BQ, Finkbeiner WE, Wine JJ, Mrsny RJ, Widdicombe JH: Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl-secretion. Am J Physiol 1994; 266:L493-L501.
153. Forbes II: Human airway epithelial cell lines for in vitro drug transport and metabolism studies. Pharm Sci Technolo Today 2000; 3: 18-27.
154. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC: CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994; 10: 38-47.
155. Ehrhardt C, Kneuer C, Laue M, Schaefer UF, Kim KJ, Lehr CM: 16HBE14o-human bronchial epithelial cell layers express p-glycoprotein, lung resistance-related protein, and caveolin-1. Pharm Res 2003; 20: 545-551.
156. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, Harris CC: Transformation of human bronchial epithelial cells by infection with sv40 or adenovirus-12 sv40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing sv40 early region genes. Cancer Res 1988; 48: 1904-1909.
157. Eaton EA, Walle UK, Wilson HM, Aberg G, Walle T: Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. Br J Clin Pharmacol 1996; 41: 201-206.
158. Proud D, Subauste MC, Ward PE: Glucocorticoids do not alter peptidase expression on a human bronchial epithelial cell line. Am J Respir Cell Mol Biol 1994; 11: 57-65.
159. Mayer AK, Bartz H, Fey F, Schmidt LM, Dalpke AH: Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment. Eur J Immunol 2008; 38: 1689-1699.
160. Sun W, Wu R, Last JA: Effects of exposure to environmental tobacco smoke on a human tracheobronchial epithelial cell line. Toxicology 1995; 100: 163-174.
161. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973; 51: 1417-1423.
162. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G: A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976; 17: 62-70.
163. Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL: Characterization of the a549 cell line as a type ii pulmonary epithelial cell model for drug metabolism. Exp Cell Res 1998; 243: 359-366.
164. Kim KJ, Borok Z, Crandall ED: A useful in vitro model for transport studies of alveolar epithelial barrier. Pharm Res 2001; 18: 253-255.
165. Winton HL, Wan H, Cannell MB, Gruenert DC, Thompson PJ, Garrod DR, Stewart GA, Robinson C: Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability. Clin Exp Allergy 1998; 28: 1273-1285.
166. Caraballo JC, Yshii C, Westphal W, Moninger T, Comellas AP: Ambient particulate matter affects occludin distribution and increases alveolar transepithelial electrical conductance. Respirology 2011; 16: 340-349.
167. Rothen-Rutishauser BM, Kiama SG, Gehr P: A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 2005; 32: 281-289.
168. Duncan JE, Whitsett JA, Horowitz AD: Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro. Hum Gene Ther 1997; 8: 431-438.
169. Rehan VK, Torday JS, Peleg S, Gennaro L, Vouros P, Padbury J, Rao DS, Reddy GS: 1', 25-dihydroxy-3-epi-Vitamin D 3, a natural metabolite of 1', 25-dihydroxy Vitamin D 3 : production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab 2002; 76: 46-56.
170. Newton DA, Rao KM, Dluhy RA, Baatz JE: Hemoglobin is expressed by alveolar epithelial cells. J Biol Chem 2006; 281: 5668-5676.
171. Zhang L, Whitsett JA, Stripp BR: Regulation of Clara cell secretory protein gene transcription by thyroid transcription factor-1. Biochim Biophys Acta 1997; 1350: 359-367.
172. Shlyonsky V, Goolaerts A, van Beneden R, Sariban-Sohraby S: Differentiation of epithelial Na + channel function: an in vitro model. J Biol Chem 2005; 280: 24181-24187.
173. Woollhead AM, Baines DL: Forskolin-induced cell shrinkage and apical translocation of functional enhanced green fluorescent protein-human alphaenac in H441 lung epithelial cell monolayers. J Biol Chem 2006; 281: 5158-5168.
174. Hermanns MI, Unger RE, Kehe K, Peters K, Kirkpatrick CJ: Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Lab Invest 2004; 84: 736-752.
175. Papritz M, Pohl C, Wubbeke C, Moisch M, Hofmann H, Hermanns MI, Thiermann H, Kirkpatrick CJ, Kehe K: Side-specific effects by cadmium exposure: apical and basolateral treatment in a coculture model of the blood-air barrier. Toxicol Appl Pharmacol 2010; 245: 361-369.
176. Gallucci S, Lolkema M, Matzinger P: Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255.
177. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor ?. J Exp Med 1994; 179: 1109-1118.
178. Shin SH, Lee SH, Jeong HS, Kita H: The effect of nasal polyp epithelial cells on eosinophil activation. Laryngoscope 2003; 113: 1374-1377.
179. Shin SH, Lee YH, Jeon CH: Protease-dependent activation of nasal polyp epithelial cells by airborne fungi leads to migration of eosinophils and neutrophils. Acta Otolaryngol 2006; 126: 1286-1294.
180. Devalia JL, Sapsford RJ, Rusznak C, Davies RJ: The effect of human eosinophils on cultured human nasal epithelial cell activity and the influence of nedocromil sodium in vitro. Am J Respir Cell Mol Biol 1992; 7: 270-277.
181. Pompen M, Smids BS, Dingemans KP, Jansen HM, Out TA, Lutter R: Lung epithelial H292 cells induce differentiation of immature human HMC-1 mast cells by interleukin-6 and stem cell factor. Clin Exp Allergy 2000; 30: 1104-1112.
182. Varsano S, Lazarus SC, Gold WM, Nadel JA: Selective adhesion of mast cells to tracheal epithelial cells in vitro. J Immunol 1988; 140: 2184-2192.
183. Nguyen Hoang AT, Chen P, Juarez J, Sachamitr P, Billing B, Bosnjak L, Dahlen B, Coles M, Svensson M: Dendritic cell functional properties in a three-dimensional tissue model of human lung mucosa. Am J Physiol Lung Cell Mol Physiol 2012; 302: L226-L237.
184. Sachs LA, Finkbeiner WE, Widdicombe JH: Effects of media on differentiation of cultured human tracheal epithelium. In Vitro Cell Dev Biol Anim 2003; 39: 56-62.
185. Widdicombe JH, Sachs LA, Finkbeiner WE: Effects of growth surface on differentiation of cultures of human tracheal epithelium. In Vitro Cell Dev Biol Anim 2003; 39: 51-55.
186. Behrens I, Kissel T: Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Eur J Pharm Sci 2003; 19: 433-442.
187. Briske-Anderson MJ, Finley JW, Newman SM: The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc Soc Exp Biol Med 1997; 214: 248-257.
188. de Jong PM, van Sterkenburg MA, Hesseling SC, Kempenaar JA, Mulder AA, Mommaas AM, Dijkman JH, Ponec M: Ciliogenesis in human bronchial epithelial cells cultured at the air-liquid interface. Am J Respir Cell Mol Biol 1994; 10: 271-277.
189. Florea BI, Molenaar TJ, Bot I, Michon IN, Kuiper J, van Berkel TJ, Junginger HE, Biessen EA, Borchard G: Identification of an internalising peptide in differentiated Calu-3 cells by phage display technology; application to gene delivery to the airways. J Drug Target 2003; 11: 383-390.
190. Florea BI, Cassara ML, Junginger HE, Borchard G: Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release 2003; 87: 131-138.
191. Aufderheide M, Mohr U: Cultex-an alternative technique for cultivation and exposure of cells of the respiratory tract to airborne pollutants at the air/liquid interface. Exp Toxicol Pathol 2000; 52: 265-270.
192. Ehrhardt C, Fiegel J, Fuchs S, Abu-Dahab R, Schaefer UF, Hanes J, Lehr CM: Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers. J Aerosol Med 2002; 15: 131-139.
193. Chan RW, Yuen KM, Yu WC, Ho CC, Nicholls JM, Peiris JS, Chan MC: Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation. PLoS One 2010; 5:e8713.
194. Loman S, Radl J, Jansen HM, Out TA, Lutter R: Vectorial transcytosis of dimeric IgA by the Calu-3 human lung epithelial cell line: upregulation by IFN-gamma. Am J Physiol 1997; 272:L951-L958.
195. Griffith LG, Swartz MA: Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006; 7: 211-224.
196. Nickerson CA, Richter EG, Ott CM: Studying host-pathogen interactions in 3-D: organotypic models for infectious disease and drug development. J Neuroimmune Pharmacol 2007; 2: 26-31.
197. Yamada KM, Cukierman E: Modeling tissue morphogenesis and cancer in 3D. Cell 2007; 130: 601-610.
198. Carterson AJ, Honer zu Bentrup K, Ott CM, Clarke MS, Pierson DL, Vanderburg CR, Buchanan KL, Nickerson CA, Schurr MJ: A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for pseudomonas aeruginosa pathogenesis. Infect Immun 2005; 73: 1129-1140.
199. Crabbe A, Sarker SF, van Houdt R, Ott CM, Leys N, Cornelis P, Nickerson CA: Alveolar epithelium protects macrophages from quorum sensing-induced cytotoxicity in a threedimensional co-culture model. Cell Microbiol 2011; 13: 469-481.
200. Hammond TG, Hammond JM: Optimized suspension culture: the rotating-wall vessel. Am J Physiol Renal Physiol 2001; 281:F12-F25.
201. Lopez-Souza N, Dolganov G, Dubin R, Sachs LA, Sassina L, Sporer H, Yagi S, Schnurr D, Boushey HA, Widdicombe JH: Resistance of differentiated human airway epithelium to infection by rhinovirus. Am J Physiol Lung Cell Mol Physiol 2004; 286: L373-L381.
202. Dahl R, Mygind N: Anatomy, physiology and function of the nasal cavities in health and disease. Adv Drug Deliv Rev 1998; 29: 3-12.
203. Dimova S, Brewster ME, Noppe M, Jorissen M, Augustijns P: The use of human nasal in vitro cell systems during drug discovery and development. Toxicol In Vitro 2005; 19: 107-122.
204. Castro M, Kraft M (eds): Clinical Asthma. Philadelphia, Mosby Elsevier, 2008.